Author: Fraser, L.
Paper Title Page
THOAB02 Options for UK Technetium-99m Production using Accelerators 2815
 
  • H.L. Owen
    UMAN, Manchester, United Kingdom
  • J.R. Ballinger
    KCL, London, United Kingdom
  • J. Buscombe
    Addenbrooke's Hospital, Cambridge, United Kingdom
  • R.J. Clarke
    STFC/RAL, Chilton, Didcot, Oxon, United Kingdom
  • E. Denton
    Norfolk and Norwich University Hospital, Norwich, United Kingdom
  • B. Ellis
    Central Manchester University Hospital, Manchester, United Kingdom
  • G.D. Flux
    Royal Marsden NHS Foundation Trust, London, United Kingdom
  • L. Fraser
    PHE, London, United Kingdom
  • B.J. Neilly
    University of Glasgow, Glasgow, United Kingdom
  • A. Paterson
    The Society of Radiographers, London, United Kingdom
  • A. Perkins
    University of Nottingham, Nottingham, United Kingdom
  • A.F. Scarsbrook
    Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, United Kingdom
 
  Recent and ongoing shortages in reactor-based supplies of Molybdenum-99 for hospital production of the important medical radioisotope Technetium-99m have prompted the re-examination of the alternative production methods using conventional and laser-based particle accelerators. At present the UK has no domestic Technetium-99m production and relies exclusively on Technetium-99m generators manufactured overseas; the National Health Service, with professional partners, is therefore examining the options for domestic production to increase security of supply. In this paper we review the accelerator-based methods from a UK perspective, and outline the most promising methods for short- and medium-term supply, which include low-energy cyclotron and photonuclear reaction routes using enriched Molybdenum-100 targets.  
slides icon Slides THOAB02 [38.942 MB]  
DOI • reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2014-THOAB02  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)